Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The “cutting” edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies

The “cutting” edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies. Transfus Apheresis Sci. 2005; 32:177-84.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.